









市場
/
株式
/
nasdaq-cphi
/

China Pharma Holdings Inc

CPHI

1.985USD

+0.020+1.02%

終値 09/19, 16:00（ET）15分遅れの株価

6.48M時価総額

損失額直近12ヶ月PER



China Pharma Holdings Inc

1.985

+0.020+1.02%

概要企業名金融分析

China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.

企業情報

企業コードCPHI

会社名China Pharma Holdings Inc

上場日Feb 15, 2000

最高経営責任者「CEO」Ms. Zhilin Li

従業員数224

証券種類Ordinary Share

決算期末Feb 15

本社所在地2nd Floor, No. 17, Jinpan Road

都市HAIKOU

証券取引所NYSE American Consolidated

国China

郵便番号570216

電話番号8689866811730

ウェブサイトhttp://www.chinapharmaholdings.com

企業コードCPHI

上場日Feb 15, 2000

最高経営責任者「CEO」Ms. Zhilin Li

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Zhilin Li

Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer

302.76K

Ms. Heung Mei Tsui

Director

18.63K

Mr. Gene Michael Bennett

Independent Director

Mr. Baowen Dong

Independent Director

Yingwen Zhang

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Zhilin Li

Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer

302.76K

Ms. Heung Mei Tsui

Director

18.63K

Mr. Gene Michael Bennett

Independent Director

Mr. Baowen Dong

Independent Director

Yingwen Zhang

Independent Director

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

事業別USD

会社名

収益

比率

Domestic Pharmaceuticals

1.14M

0.00%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Domestic Pharmaceuticals

1.14M

0.00%

株主

更新時刻: Sat, Aug 23

株主統計

種類

株主統計

比率

Li (Zhilin)

9.28%

Liu (Tao Chengdu)

9.20%

UBS Financial Services, Inc.

2.18%

Streeterville Capital LLC

2.02%

Citadel Advisors LLC

0.71%

他の

76.61%

株主統計

比率

Li (Zhilin)

9.28%

Liu (Tao Chengdu)

9.20%

UBS Financial Services, Inc.

2.18%

Streeterville Capital LLC

2.02%

Citadel Advisors LLC

0.71%

他の

76.61%

種類

株主統計

比率

Individual Investor

19.05%

Investment Advisor

2.68%

Corporation

2.02%

Hedge Fund

0.96%

他の

75.29%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

721.01K

22.10%

+60.71K

2025Q1

1.02M

31.30%

+60.71K

2024Q4

10.05M

52.18%

+471.51K

2024Q3

9.91M

65.84%

+3.60M

2024Q2

9.93M

65.98%

+3.66M

2024Q1

9.99M

66.39%

+3.80M

2023Q4

6.74M

97.18%

+3.36M

2023Q3

3.69M

42.02%

+3.06M

2023Q2

907.22K

57.28%

+262.90K

2023Q1

923.80K

58.50%

+308.99K

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Li (Zhilin)

302.76K

9.28%

Mar 24, 2025

Liu (Tao Chengdu)

300.00K

9.2%

Mar 24, 2025

UBS Financial Services, Inc.

10.45K

0.32%

+7.30K

+231.58%

Mar 31, 2025

Streeterville Capital LLC

65.84K

2.02%

+55.52K

+538.08%

Dec 31, 2023

Citadel Advisors LLC

5.31K

0.16%

+5.31K

Mar 31, 2025

Tsui (Heung Mei)

18.63K

0.57%

Mar 24, 2025

HRT Financial LP

2.51K

0.08%

+2.51K

Mar 31, 2025

Two Sigma Investments, LP

2.53K

0.08%

-4.45K

-63.71%

Mar 31, 2025

XTX Markets LLC

8.38K

0.26%

+1.67K

+24.84%

Mar 31, 2025

詳細を見る